Synergy between vitamin D3 and toll-like receptor agonists regulates human dendritic cell response during maturation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Brosbøl Ravnborg, Anne ^a   Bundgaard, Bettina ^a   Höllsberg, Per ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; COLECALCIFEROL; COLECALCIFEROL RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; CALCITRIOL RECEPTOR; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 12; LEUKOCYTE ANTIGEN; TOLL LIKE RECEPTOR; VDR PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR INTERACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; AGONISTS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MONONUCLEAR CELL; DRUG EFFECT;

ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CHOLECALCIFEROL; DENDRITIC CELLS; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN; RECEPTORS, CALCITRIOL; TOLL-LIKE RECEPTORS;

EID: 84877965360     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/807971     Document Type: Article

References (29)

1. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588 (Pubitemid 28155090)
2. Steinbrink K., Wölfl M., Jonuleit H., Knop J., Enk A. H., Induction of tolerance by IL-10-treated dendritic cells. The Journal of Immunology 1997 159 10 4772 4780 2-s2.0-0031573204 (Pubitemid 127471012)
3. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. The Journal of Immunology 2000 164 9 4443 4451 2-s2.0-0034178251 (Pubitemid 30238038)
4. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. The Journal of Immunology 2000 164 5 2405 2411 2-s2.0-0034161714 (Pubitemid 30115468)
5. 3 or dexamethasone: differential role for PD-L1. European Journal of Immunology 2009 39 11 3147 3159 2-s2.0-70449368149 10.1002/eji.200839103
6. + T cells. The Journal of Immunology 2010 184 4 1765 1775 2-s2.0-77949893984 10.4049/jimmunol.0902133
7. Mahnke K., Johnson T. S., Ring S., Enk A. H., Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. Journal of Dermatological Science 2007 46 3 159 167 2-s2.0-34247177494 10.1016/j.jdermsci.2007.03.002 (Pubitemid 46601842)
8. Maldonado R. A., von Andrian U. H., How tolerogenic dendritic cells induce regulatory T cells. Advances in Immunology 2010 108 111 165 2-s2.0-78149277909 10.1016/B978-0-12-380995-7.00004-5
9. 3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement. Immunobiology 2011 216 9 988 996 2-s2.0-79960843533 10.1016/j.imbio.2011.03.011
10. 3 receptor in the immune system. Archives of Biochemistry and Biophysics 2000 374 2 334 338 2-s2.0-0034652314 10.1006/abbi.1999.1605 (Pubitemid 30120270)
11. 3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. The Journal of Immunology 2007 178 1 145 153 2-s2.0-33845949937 (Pubitemid 46033595)
12. 3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clinical Immunology 2009 133 1 69 77 2-s2.0-69949164976 10.1016/j.clim.2009.06.011
13. 3: basic concepts. Journal of Steroid Biochemistry and Molecular Biology 2005 97 1-2 93 101 2-s2.0-27544499686 10.1016/j.jsbmb.2005.06.002 (Pubitemid 41546218)
14. Ascherio A., Munger K. L., Simon K. C., Vitamin D and multiple sclerosis. The Lancet Neurology 2010 9 6 599 612 2-s2.0-77952314178 10.1016/S1474-4422(10) 70086-7
15. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C., Vitamin D: modulator of the immune system. Current Opinion in Pharmacology 2010 10 4 482 496 2-s2.0-77955251897 10.1016/j.coph.2010.04.001
16. Spach K. M., Nashold F. E., Dittel B. N., Hayes C. E., IL-10 signaling is essential for 1,25-dihydroxyvitamin D 3-mediated inhibition of experimental autoimmune encephalomyelitis. The Journal of Immunology 2006 177 9 6030 6037 2-s2.0-33750314525 (Pubitemid 44628817)
17. 3 analogs as immunomodulatory agents. Trends in Molecular Medicine 2002 8 4 174 179 2-s2.0-0036220629 10.1016/S1471-4914(02)02294-3 (Pubitemid 34297090)
18. Adorini L., Penna G., Control of autoimmune diseases by the vitamin D endocrine system. Nature Clinical Practice Rheumatology 2008 4 8 404 412 2-s2.0-48749085956 10.1038/ncprheum0855
19. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S. R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D. L., Wagner M., Bals R., Steinmeyer A., Zügel U., Gallo R. L., Eisanberg D., Hewison M., Hollis B. W., Adams J. S., Bloom B. R., Modlin R. L., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006 311 5768 1770 1773 2-s2.0-33645224419 10.1126/science.1123933
20. Kawai T., Akira S., Pathogen recognition with Toll-like receptors. Current Opinion in Immunology 2005 17 4 338 344 2-s2.0-20544474210 10.1016/j.coi.2005.02.007 (Pubitemid 40848534)
21. Berrington W. R., Hawn T. R., Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunological Reviews 2007 219 1 167 186 2-s2.0-34548559007 10.1111/j.1600-065X.2007.00545.x (Pubitemid 47390000)
22. Daniel C., Sartory N. A., Zahn N., Radeke H. H., Stein J. M., Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Journal of Pharmacology and Experimental Therapeutics 2008 324 1 23 33 2-s2.0-37349104972 10.1124/jpet.107.127209 (Pubitemid 350294165)
23. Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S., The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochimica et Biophysica Acta 2011 1813 5 878 888 2-s2.0-79955650634 10.1016/j.bbamcr.2011.01. 034
24. Greenhill C. J., Rose-John S., Lissilaa R., Ferlin W., Ernst M., Hertzog P. J., Mansell A., Jenkins B. J., IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. The Journal of Immunology 2011 186 2 1199 1208 10.4049/jimmunol.1002971
25. 3 analog augmented interleukin-8 production by human monocytic cells in response to various microbe-related synthetic ligands, especially NOD2 agonistic muramyldipeptide. International Immunopharmacology 2013 15 1 15 22 10.1016/j.intimp.2012.10.027
26. 3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochemical and Biophysical Research Communications 1991 176 3 1020 1026 2-s2.0-0025912159
27. 3 regulates NF- B DNA binding activity in cultured normal human keratinocytes through an increase in I B α expression. Archives of Dermatological Research 2004 296 5 195 202 2-s2.0-8644271518 10.1007/s00403-004-0509-9 (Pubitemid 39506515)
28. Tang X., Pan Y., Zhao Y., Vitamin D inhibits the expression of interleukin-8 in human periodontal ligament cells stimulated with Porphyromonas gingivalis. Archives of Oral Biology 2012 58 4 397 407 10.1016/j.archoralbio. 2012.09.010
29. Benrashid M., Moyers K., Mohty M., Savani B. N., Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: implication for preventive therapy. Experimental Hematology 2012 40 263 267